Giant cell lesions of the periodontium are best considered as?
Which of the following tumors most closely resembles a hemangiopericytoma?
In Duchenne muscular dystrophy, the defect is in the gene producing which protein?
In Duchenne's muscular dystrophy, what is the state of the calf muscle?
Calcification of the intervertebral disc is a feature of which condition?
Which of the following bone diseases characteristically exhibits a single lesion in a single bone?
Which of the following is TRUE about desmoid tumors?
Cystosarcoma phylloides is a tumor of which organ?
What is the most common soft tissue tumor in adults?
What is the most common histological type of rhabdomyosarcoma?
Explanation: Giant cell lesions of the periodontium, most notably the **Peripheral Giant Cell Granuloma (PGCG)**, are classified as **non-neoplastic reactive lesions**. They typically arise as a response to local irritation or chronic trauma (such as dental plaque, calculus, or ill-fitting dentures) rather than being true tumors [1]. **Why the correct answer is right:** * **Pathogenesis:** These lesions represent an exuberant tissue response [1]. Histologically, they are characterized by a proliferation of multinucleated giant cells in a vascular stroma. * **Behavior:** Unlike neoplasms, they do not show autonomous growth. They are localized, non-encapsulated inflammatory hyperplasias that often regress or resolve once the inciting stimulus (irritant) is removed and the lesion is surgically excised [1]. **Why the incorrect options are wrong:** * **A & C (Benign/Malignant Neoplasms):** A neoplasm implies a genetic mutation leading to uncontrolled clonal expansion. PGCG does not demonstrate this; it is a reactive process [1]. While "Central Giant Cell Granuloma" (found within the bone) can sometimes behave aggressively, the peripheral periodontal version is strictly reactive. * **D (None of the above):** This is incorrect as the reactive nature of these lesions is a well-established pathological classification. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Appearance:** PGCG presents as a firm, red-to-blue, pedunculated or sessile mass on the gingiva or alveolar ridge. * **Differential Diagnosis:** Must be clinically differentiated from **Pyogenic Granuloma** (which lacks giant cells) and **Fibroma** [1]. * **Radiology:** Usually shows no bone involvement, but may cause "cupping" resorption of the underlying alveolar bone. * **Systemic Link:** Always rule out **Hyperparathyroidism** (Brown tumor) if multiple giant cell lesions are present, as they are histologically indistinguishable. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 735-736.
Explanation: The correct answer is **Glomus tumor**. The resemblance between a glomus tumor and a hemangiopericytoma lies in their **perivascular origin** [1]. A glomus tumor is a benign neoplasm arising from the modified smooth muscle cells of the **glomus body** (a specialized arteriovenous anastomosis involved in thermoregulation) [1]. Historically, hemangiopericytoma was defined by its "staghorn" vascular pattern and perivascular spindle cells [1]. While the term "hemangiopericytoma" is now largely replaced by the **Solitary Fibrous Tumor (SFT)** spectrum in modern pathology, the classic description emphasizes cells surrounding vascular spaces, a feature shared by the glomus tumor [1]. **Analysis of Incorrect Options:** * **A. Hemangioma:** This is a benign proliferation of blood vessels (capillary or cavernous) lined by endothelial cells, not perivascular cells [1]. * **C. Ewing’s Sarcoma:** A small round blue cell tumor characterized by the t(11;22) translocation. While it can be highly vascular, its cellular morphology does not mimic pericytes. * **D. Plasmacytoma:** A localized collection of neoplastic plasma cells (clock-face chromatin, perinuclear hof). It is a hematological malignancy unrelated to vascular pericytes. **NEET-PG High-Yield Pearls:** * **Glomus Tumor Triad:** Exquisite pain, localized tenderness, and sensitivity to cold. * **Common Site:** Subungual region (under the fingernails). * **Immunohistochemistry (IHC):** Glomus tumors are positive for **SMA (Smooth Muscle Actin)** and negative for endothelial markers like CD31/CD34 (unlike hemangiomas). * **Staghorn/Deer-horn vasculature:** This is the classic histological buzzword for Solitary Fibrous Tumor (formerly hemangiopericytoma). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 523-524.
Explanation: **Explanation:** **1. Why Dystrophin is Correct:** Duchenne Muscular Dystrophy (DMD) is an **X-linked recessive** disorder caused by a mutation in the **DMD gene**, which is the largest known human gene. This gene encodes **Dystrophin**, a critical cytoplasmic protein that acts as a "shock absorber." It links the intracellular cytoskeleton (actin) to the extracellular matrix via the dystroglycan complex. In DMD, there is a complete absence of dystrophin, leading to membrane instability, calcium influx, and progressive myofiber necrosis [1]. **2. Analysis of Incorrect Options:** * **Alpha-actinin:** This protein anchors actin filaments to the Z-disks in skeletal muscle. While vital for sarcomere structure, it is not the primary defect in DMD. * **Nebulin:** This is a giant protein that acts as a "molecular ruler" to regulate the length of actin filaments. Mutations here are associated with Nemaline myopathy, not DMD. * **Desmin:** An intermediate filament protein that integrates the sarcolemma, Z-disk, and nuclear envelope. Mutations in desmin lead to Desmin-related myofibrillar myopathy. **3. NEET-PG High-Yield Pearls:** * **Genetics:** DMD is caused by **out-of-frame deletions** (complete absence of protein), whereas **Becker Muscular Dystrophy (BMD)** is caused by **in-frame mutations** (truncated, partially functional protein), leading to a milder phenotype [1]. * **Clinical Signs:** Look for **Gower’s sign** (using hands to "climb up" the body to stand) and **pseudohypertrophy of calves** (muscle replaced by fat and fibrosis). * **Diagnosis:** Elevated **Creatine Kinase (CK)** levels are present from birth. Gold standard for diagnosis is genetic testing (MLPA); muscle biopsy shows variation in fiber size and endomysial fibrosis [1]. * **Cause of Death:** Usually respiratory failure or dilated cardiomyopathy in the second decade of life. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1244-1245.
Explanation: **Explanation:** In **Duchenne Muscular Dystrophy (DMD)**, the calf muscles (gastrocnemius and soleus) characteristically appear enlarged, a phenomenon known as **Pseudohypertrophy**. **Why Pseudohypertrophy is the correct answer:** DMD is an X-linked recessive disorder caused by a mutation in the **Dystrophin gene** (the largest known human gene) [1]. The absence of dystrophin leads to progressive myofiber necrosis. As muscle fibers are lost, they are replaced by an extensive proliferation of **fibro-fatty tissue** (fat and connective tissue). This replacement increases the bulk of the muscle, making it look "hypertrophied" to the naked eye, while the actual functional muscle tissue is severely diminished. **Analysis of Incorrect Options:** * **Hypertrophied:** True hypertrophy involves an increase in the size of individual muscle fibers (e.g., in athletes). In DMD, the muscle fibers are actually dying, not growing [1]. * **Atrophied:** While the muscle fibers themselves undergo atrophy and necrosis, the overall clinical appearance of the calf is one of enlargement due to fat deposition, making "atrophied" clinically inaccurate for the calf. * **Pseudoatrophied:** This is not a standard pathological term used to describe the clinical presentation of DMD. **NEET-PG High-Yield Pearls:** * **Gower’s Sign:** Patients use their hands to "climb up" their own legs to stand up due to proximal muscle weakness. * **Biochemical Marker:** Serum **Creatine Kinase (CK)** levels are massively elevated (often 10–100x normal) from birth. * **Becker Muscular Dystrophy:** A milder form where dystrophin is truncated/mutated but present (unlike DMD where it is absent) [1]. * **Cause of Death:** Usually respiratory failure or **Dilated Cardiomyopathy**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Peripheral Nerves and Skeletal Muscles, pp. 1244-1245.
Explanation: **Explanation:** **Alkaptonuria** is an autosomal recessive metabolic disorder caused by a deficiency of the enzyme **homogentisate 1,2-dioxygenase**. This leads to the accumulation of homogentisic acid (HGA) in the body. HGA binds to collagen in connective tissues, a process known as **Ochronosis**. In the spine, this pigment deposition leads to the degeneration, narrowing, and subsequent **calcification of the intervertebral discs**. On X-ray, this appears as "wafer-like" calcification of multiple discs, which is a classic diagnostic hallmark. **Analysis of Incorrect Options:** * **Ankylosing Spondylitis:** Characterized by "Bamboo spine" due to marginal syndesmophytes and fusion of the sacroiliac joints, but it does not typically feature primary disc calcification. * **Hyperparathyroidism:** Associated with "Rugger-jersey spine" (subperiosteal resorption and sclerosis) and metastatic calcification in soft tissues, but not specifically isolated intervertebral disc calcification. * **Charcot’s Disease (Neuropathic Joint):** Leads to severe joint destruction, disorganized bone formation (debris), and sclerosis due to loss of sensation, but not the systematic calcification of discs. **High-Yield NEET-PG Pearls:** * **Triad of Alkaptonuria:** 1. Homogentisic aciduria (urine turns black on standing/alkalinization), 2. Ochronosis (blue-black pigmentation of cartilage/sclera), 3. Ochronotic arthritis. * **Radiology:** Look for the "wafer-like" calcification of intervertebral discs and narrowing of the joint space. * **Diagnosis:** Confirmed by detecting homogentisic acid in urine using thin-layer chromatography or the Ferric Chloride test (transient green color).
Explanation: **Explanation:** The correct answer is **Central Giant Cell Granuloma (CGCG)**. **1. Why Central Giant Cell Granuloma is Correct:** CGCG is a benign, non-neoplastic intraosseous lesion, most commonly occurring in the mandible or maxilla. It is characteristically a **solitary (monostotic)** lesion. Pathologically, it consists of a fibrovascular stroma populated by multinucleated giant cells. While it can be locally aggressive, it does not involve multiple bones simultaneously unless associated with systemic syndromes (like Noonan syndrome), which is rare. **2. Why the Other Options are Incorrect:** * **Osteopetrosis (Marble Bone Disease):** This is a **hereditary** metabolic bone disorder caused by defective osteoclast function. Since it is a genetic defect affecting the entire skeletal system, it is inherently **generalized/polyostotic**, leading to increased bone density throughout the body. * **Paget’s Disease (Osteitis Deformans):** While Paget’s can be monostotic (15% of cases), it is most frequently **polyostotic** (85% of cases), involving the axial skeleton, femur, and skull [1]. It is characterized by disordered bone remodeling (mosaic pattern). * **Polyostotic Fibrous Dysplasia:** As the name implies, this form of fibrous dysplasia involves **multiple bones** [2]. It is often associated with endocrine abnormalities, such as in **McCune-Albright Syndrome** (triad of polyostotic fibrous dysplasia, café-au-lait spots, and precocious puberty) [2], [3]. **High-Yield Clinical Pearls for NEET-PG:** * **CGCG:** Most common in females under 30; frequently crosses the midline of the jaw. * **Brown Tumor:** Histologically identical to CGCG; always rule out **Hyperparathyroidism** if multiple giant cell lesions are found. * **Cherubism:** A hereditary condition presenting with bilateral, symmetrical giant cell lesions in the jaws of children. * **Monostotic Fibrous Dysplasia:** The most common form of fibrous dysplasia (70%), but "Polyostotic" was specifically mentioned in the options [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1192-1194. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, p. 1208. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1208-1209.
Explanation: **Explanation:** **Desmoid tumors** (also known as deep fibromatosis) are locally aggressive, non-metastasizing fibroblastic neoplasms. **1. Why Option A is Correct:** The molecular hallmark of desmoid tumors is the **overexpression of beta-catenin** [1]. This occurs due to mutations in either the **CTNNB1 gene** (sporadic cases) or the **APC gene** (associated with Familial Adenomatous Polyposis/Gardner Syndrome) [1]. Both mutations prevent the degradation of beta-catenin, leading to its accumulation in the nucleus, where it drives the transcription of genes promoting cell proliferation. **2. Why the Other Options are Incorrect:** * **Option B:** Histologically, desmoid tumors consist of bland, **benign-appearing** spindle cells (fibroblasts/myofibroblasts) arranged in long fascicles. They lack significant cytologic atypia and typically show **low mitotic activity**, despite their infiltrative growth. * **Option C:** The primary modality of treatment is **surgical excision** with wide margins. However, due to high recurrence rates, a "watch and wait" approach or systemic therapies are increasingly considered. Radiotherapy is generally reserved for unresectable or recurrent cases. * **Option D:** Desmoid tumors are locally invasive and have a high rate of local recurrence, but they **do not metastasize**. **High-Yield Clinical Pearls for NEET-PG:** * **Gardner Syndrome:** Remember the triad of FAP, Osteomas, and Desmoid tumors [1]. * **Location:** Often occur in the abdominal wall of pregnant/postpartum women or intra-abdominally in FAP patients [1]. * **Staining:** Strong **nuclear** staining for beta-catenin on Immunohistochemistry (IHC) is diagnostic [1]. * **Estrogen Association:** These tumors can be estrogen-sensitive; hence, they are more common in females of reproductive age. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 691-692.
Explanation: **Explanation:** **Cystosarcoma Phyllodes** (or Phyllodes tumor) is a fibroepithelial neoplasm of the **Breast** [1]. It arises from the intralobular stroma and is characterized by a "leaf-like" (phyllodes) growth pattern of hypercellular stroma pushing into the overlying epithelium [1]. 1. **Why Breast is Correct:** Phyllodes tumors are distinct from common fibroadenomas due to their increased stromal cellularity, mitotic activity, and potential for malignancy [1], [2]. They typically present in women in their 40s and 50s as large, rapidly growing, painless masses. 2. **Why Other Options are Incorrect:** * **Liver:** Primary tumors include Hepatocellular Carcinoma or Hemangiomas; phyllodes-type morphology is not seen here. * **Colon:** Common tumors are Adenocarcinomas or GISTs. * **Uterus:** While the uterus has stromal tumors (e.g., Leiomyomas or Endometrial Stromal Sarcomas), Cystosarcoma Phyllodes is specific to the mammary gland. **High-Yield Clinical Pearls for NEET-PG:** * **Morphology:** Characterized by "leaf-like" cytoplasmic projections and increased stromal cellularity [1]. * **Grading:** They are classified as Benign, Borderline, or Malignant based on mitotic figures, stromal overgrowth, and nuclear atypia [1], [2]. * **Metastasis:** Unlike breast adenocarcinoma, malignant phyllodes tumors spread via the **hematogenous route** (most commonly to the lungs), not the lymphatics [1]. Axillary lymph node dissection is usually not required. * **Treatment:** Wide local excision with negative margins is the gold standard to prevent local recurrence [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, p. 1074. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 459-462.
Explanation: **Malignant Fibrous Histiocytoma (MFH)**, now more accurately reclassified in modern WHO terminology as **Undifferentiated Pleomorphic Sarcoma (UPS)**, is historically and clinically recognized as the most common soft tissue sarcoma in adults, particularly in the 50–70 age group. It typically arises in the deep soft tissues of the extremities (especially the thigh) or the retroperitoneum. It is characterized histologically by a "storiform" or cartwheel growth pattern of spindle cells and significant cellular pleomorphism. **Analysis of Options:** * **A. Embryonal Rhabdomyosarcoma:** This is the most common soft tissue sarcoma in **children** (usually under age 10) [1], typically occurring in the head, neck, or genitourinary tract. * **B. Liposarcoma:** This is the second most common soft tissue sarcoma in adults [1]. While very frequent, it statistically follows UPS/MFH in overall incidence [1]. * **C. Synovial Sarcoma:** This is a common sarcoma in young adults (20–40 years) and is characterized by a unique t(X;18) translocation [1]. It is not the most common overall [1]. **High-Yield Pearls for NEET-PG:** * **Most common benign soft tissue tumor (Adults):** Lipoma [1]. * **Most common malignant soft tissue tumor (Adults):** Malignant Fibrous Histiocytoma (UPS). * **Most common soft tissue sarcoma (Children):** Rhabdomyosarcoma [1]. * **Most common site for MFH:** Lower extremity (Thigh). * **Key Histology:** Storiform pattern and marked nuclear atypia. * **Note on Nomenclature:** If "Undifferentiated Pleomorphic Sarcoma" appears in options instead of MFH, it is the preferred modern term. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1222-1226.
Explanation: **Explanation:** **Rhabdomyosarcoma (RMS)** is the most common soft tissue sarcoma of childhood and adolescence. It is a malignant tumor derived from primitive mesenchymal cells that show evidence of skeletal muscle differentiation. **1. Why Embryonal is Correct:** The **Embryonal subtype** is the most common histological variant, accounting for approximately **60% of all cases**. It typically affects children under the age of 10 and most frequently occurs in the head and neck region (e.g., orbit, nasopharynx) or the genitourinary tract [1]. Microscopically, it mimics various stages of muscle development, featuring spindle-shaped or round cells with a "tadpole" or "tennis racket" appearance (rhabdomyoblasts). **2. Analysis of Incorrect Options:** * **Alveolar (Option C):** This is the second most common type (approx. 20%). It usually occurs in older children/adolescents and involves the deep muscles of the extremities. It is characterized by a "cluster" appearance resembling lung alveoli and is associated with the **t(2;13)** translocation. * **Pleomorphic (Option A):** This is the rarest subtype [1]. It occurs primarily in adults and carries a poor prognosis. * **Botryoid (Option D):** This is actually a **variant of the Embryonal subtype**, not a separate main category [1]. It is characterized by grape-like clusters (sarcoma botryoides) and is typically found in hollow organs like the vagina or bladder. **High-Yield NEET-PG Pearls:** * **Marker of Choice:** **Desmin** is the most specific marker; **MyoD1** and **Myogenin** are highly sensitive nuclear markers for skeletal muscle differentiation [1]. * **Cambium Layer:** A classic histological feature of the Botryoid variant where tumor cells condense beneath the mucosal epithelium. * **Genetics:** Alveolar RMS involves the fusion of *PAX3* or *PAX7* with the *FOXO1* gene. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1224-1225.
Bone Development and Growth
Practice Questions
Fracture Healing
Practice Questions
Osteomyelitis and Infectious Diseases
Practice Questions
Metabolic Bone Diseases
Practice Questions
Bone Tumors and Tumor-like Lesions
Practice Questions
Joints and Rheumatologic Diseases
Practice Questions
Soft Tissue Tumors
Practice Questions
Muscular Dystrophies and Myopathies
Practice Questions
Diseases of Tendons and Fascia
Practice Questions
Pathology of Orthopedic Implants
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free